Louis Kayitalire is CHIEF MEDICAL OFFICER of F-star Therapeutics, Inc.. Currently has a direct ownership of 0 shares of FSTX, which is worth approximately $0. The most recent transaction as insider was on Mar 08, 2023, when has been sold 29,236 shares (Common Stock) at a price of $7.12 per share, resulting in proceeds of $208,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Louis Kayitalire Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$208,160 $7.12 p/Share
29,236 Reduced 53.89%
25,019 Common Stock
Mar 08 2023
SELL
Sale (or disposition) back to the issuer
$178,135 $7.12 p/Share
25,019 Reduced 100.0%
0 Common Stock
Nov 02 2021
SELL
Open market or private sale
$437 $6.83 p/Share
64 Reduced 0.12%
54,255 Common Stock
Oct 04 2021
SELL
Open market or private sale
$463 $7.23 p/Share
64 Reduced 0.12%
54,319 Common Stock
Jul 02 2021
SELL
Open market or private sale
$8,885 $8.43 p/Share
1,054 Reduced 1.9%
54,383 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
29,000 Added 34.35%
55,437 Common Stock
LK

Louis Kayitalire

CHIEF MEDICAL OFFICER
Cambridge, X0

Track Institutional and Insider Activities on FSTX

Follow F-star Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FSTX shares.

Notify only if

Insider Trading

Get notified when an F Star Therapeutics, Inc. insider buys or sells FSTX shares.

Notify only if

News

Receive news related to F-star Therapeutics, Inc.

Track Activities on FSTX